Search Results for: MICRONEEDLE TECHNOLOGY The New Potential
Articles
MICRONEEDLE TECHNOLOGY - The New Potential of Microneedles for Biologics & Small Molecules November 18, 2015
Lisa A. Dick, PhD, describes how microneedle technology is being applied in two new transdermal systems using solid and hollow microneedles, which have the ability to deliver small molecules as well as biologics, opening up the potential for self-administration of a broad array of APIs
Successful Transfer of NDA Acknowledged by FDA From Former Zosano Pharma to Emergex for Investigational Microneedle-Based Drug Delivery Patch December 18, 2023
Emergex Vaccines Holding Limited recently announced the company has transferred ownership, as of May 2023, of the existing US FDA New Drug Application (NDA) of the investigational MAP originally intended….
Kindeva Drug Delivery, Chiesi Group & H&T Presspart Announce Strategic Partnership for Dose Counter Technology Production July 11, 2023
Kindeva Drug Delivery and H&T Presspart are partnering with Chiesi Group for the installation of a production line for dose counter (DC) and dose indicator (DI) devices. Combining the specific….
PharmaTher Enters Process Development Agreement Eith LTS for Ketamine Microneedle Patch December 20, 2021
PharmaTher Holdings Ltd. and LTS LOHMANN Therapie-Systeme AG recently announced they have entered into a process development agreement for the clinical trial scale up of PharmaTher’s proprietary….
INTRADERMAL DELIVERY - New Technology Brings Simplicity & Scalability to Intradermal Drug Delivery March 15, 2018
Boris Stoeber, PhD, Sahan Ranamukha, PhD, and Rory St. Clair describe the Microdermics technology and its improvements over the conventional subcutaneous route of administration.
Breakthrough Brings 3M One Step Closer to Introducing New Alternative Drug Delivery Method February 4, 2015
Getting an injection at the doctor’s office typically does not rank high on many people’s wish list. Due to 3M...EXECUTIVE INTERVIEW - 4P Therapeutics: Developing New & Innovative Transdermal Products June 3, 2014
Drug Development Executive: Steven Damon, Founder of 4P Therapeutics, discusses his vision for the company and how 4P intends to create new and innovative transdermal products that meet the needs of patients, physicians, and payers.
TRANSDERMAL DELIVERY - New Frontiers in Transdermal Drug Delivery April 30, 2013
Kenneth B. Kirby and Chandan A.S. Alam, MD, are part of a team at Transdermal Delivery Solutions Corp. (TDSC) that has been leveraging its patented technology to develop a unique patchless, metered pump, spray-on drug delivery system and products.
Emergex Announces R&D Collaboration With DEKA Research & Development Corp. for Assessment of Emergex’s Immunotherapeutic Candidates With DEKA’s Intradermal Therapeutic Applicator January 16, 2024
Emergex Vaccines Holding Limited recently announced it has entered into an agreement with DEKA to assess the compatibility of Emergex’s immunotherapeutic candidates with the DEKA Intradermal Therapeutic Applicator…..
Meridian Medical Technologies Investing $100+ Million in Bridgeton, MO, Expansion April 11, 2023
Meridian Medical Technologies recently announced during National Community Development Week it will expand manufacturing capabilities in….
FORMULATION FORUM - Changing the Landscape of Nanoparticles for Long-Acting Injectable Drugs March 1, 2023
Jim Huang, PhD, and Shaukat Ali, PhD, say recently, there has been continued interest in parenteral NPs with sustained-release characteristics as more drugs discovered are poorly soluble and less bioavailable, and these challenges have led to enormous opportunities and launch of many drug products to market.
MARKET REPORT - Survey Suggests Global Innovation to Recover Much More Quickly Than Expected in 2023 February 9, 2023
After a brief fall in 2022 to a score of 6.5 – the first decline since its inception in 2018 – the index has surged to a record score of 7.4. This sudden recovery in scores over a little more than 8 months bodes extremely well for device and packaging manufacturers in the year ahead, suggesting a strong global recovery in industry outlook and confidence.
Revive Therapeutics Enters Research Collaboration Agreement With PharmaTher for Development of MDMA Transdermal Patch February 3, 2023
Revive Therapeutics Ltd. recently announced it has entered into a research collaboration agreement with PharmaTher Holdings Ltd. to evaluate the delivery of 3,4-Methylenedioxymethamphetamine (MDMA) using PharmaTher’s novel microneedle….
SPECIAL FEATURE - Solubility & Bioavailability: Utilizing Enabling Technologies March 1, 2022
Contributor Cindy H. Dubin interviews several leading companies on how they are using innovative technologies, such as lipid nanoparticles to achieve a high drug loading, combining anti-solvent continuous crystallization with micro-mixing technology to control crystallization and reduce crystal size, and how a robotic capsule can improve bioavailability in the range of 47% to 78%.
Kindeva & BOL Pharma Sign Agreement for Development of Inhaled Cannabinoid Products December 2, 2020
Kindeva Drug Delivery and Breath of Life International recently signed an agreement to study the feasibility of multiple inhaled cannabinoid products…..
MARKET BRIEF - Preferences for Targeted Therapies & Patient-Centric Approaches Drive Transformations in Oncology Drug Delivery Market May 1, 2017
Frost & Sullivan Analyst Piyush Bansal says although chemotherapy has been successfully used for inhibiting cell growth throughout the past few decades, the side effects of chemotherapy have forced researchers to look for some alternative drugs (and how to effectively deliver them) for all types of cancer.
SPECIAL FEATURE - Injectable Drug Delivery: Key Trends Define Device Design Now & in the Future August 31, 2016
Contributor Cindy H. Dubin spoke with some of the world’s leading device developers about their current injection technologies and how their devices are addressing the current trends and opportunities in the industry.
Needle-Free Technologies the Preferred Choice for Patients February 19, 2015
BCC Research reveals in its new report on needle free technologies that during the past several decades, tremendous progress has...3M DDS Announces Collaboration With Presspart Group August 25, 2014
ST. PAUL, Minn. – August 13, 2014 – 3M Drug Delivery Systems Division recently announced a new collaborative agreement with...3M DDS Announces Collaboration With Presspart Group August 18, 2014
ST. PAUL, Minn. – August 13, 2014 – 3M Drug Delivery Systems Division recently announced a new collaborative agreement with...Issues
May 2010
Amino Acid-Containing Degradable Polymers & Their Potential in Controlled Drug DeliveryAylvin A. Dias, PhD, MSc, and Marc Hendriks, PhD, MBA,...July/August 2012
FORMULATION DEVELOPMENT – Deuterium Modification as a New Branch of Medicinal Chemistry to Develop Novel, Highly Differentiated Drugs Philip Graham,...
